Skip to content
10-Q

Quarterly Report

AMBIT BIOSCIENCES CORP

0001104659-14-035218

← back to feed
Filed
May 6, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Apr 30, 2014 17.97M sh
Shares Diluted Q1 2014 · Mar 31, 2014 18.93M sh
Shares Diluted Q1 2014 · Mar 31, 2013 3.99K sh
Capex Q1 2014 · Mar 31, 2014 $113K
Capex Q1 2014 · Mar 31, 2013 $446K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$9.09M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$9.11M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $61.85M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $71.19M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $8.41M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $17.48M
Stockholders Equity Q1 2014 · Mar 31, 2014 $49.25M
Stockholders Equity Q1 2014 · Dec 31, 2013 $57.59M
Current Liabilities Q1 2014 · Mar 31, 2014 $15M
Current Liabilities Q1 2014 · Dec 31, 2013 $16.36M
Current Assets Q1 2014 · Mar 31, 2014 $63.36M
Current Assets Q1 2014 · Dec 31, 2013 $73.1M
Total Assets Q1 2014 · Mar 31, 2014 $64.25M
Total Assets Q1 2014 · Dec 31, 2013 $73.95M
Eps Diluted Q1 2014 · Mar 31, 2014 −$0.50
Eps Diluted Q1 2014 · Mar 31, 2013 −$3,019.30
Eps Basic Q1 2014 · Mar 31, 2014 −$0.50
Eps Basic Q1 2014 · Mar 31, 2013 −$3,019.30
Sga Expense Q1 2014 · Mar 31, 2014 $3.31M
Sga Expense Q1 2014 · Mar 31, 2013 $1.78M
Rd Expense Q1 2014 · Mar 31, 2014 $6.26M
Rd Expense Q1 2014 · Mar 31, 2013 $9.01M
Net Income Q1 2014 · Mar 31, 2014 −$9M
Net Income Q1 2014 · Mar 31, 2013 −$8.23M
Operating Income Q1 2014 · Mar 31, 2014 −$9.53M
Operating Income Q1 2014 · Mar 31, 2013 −$4.19M